PMID- 10601033 OWN - NLM STAT- MEDLINE DCOM- 20000111 LR - 20190516 IS - 0890-9369 (Print) IS - 0890-9369 (Linking) VI - 13 IP - 23 DP - 1999 Dec 1 TI - Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. PG - 3070-80 AB - The RAG1 and RAG2 proteins collaborate to initiate V(D)J recombination by binding recombination signal sequences (RSSs) and making a double-strand break between the RSS and adjacent coding DNA. Like the reactions of their biochemical cousins, the bacterial transposases and retroviral integrases, cleavage by the RAG proteins requires a divalent metal ion but does not involve a covalent protein/DNA intermediate. In the transposase/integrase family, a triplet of acidic residues, commonly called a DDE motif, is often found to coordinate the metal ion used for catalysis. We show here that mutations in each of three acidic residues in RAG1 result in mutant derivatives that can bind the RSS but whose ability to catalyze either of the two chemical steps of V(D)J cleavage (nicking and hairpin formation) is severely impaired. Because both chemical steps are affected by the same mutations, a single active site appears responsible for both reactions. Two independent lines of evidence demonstrate that at least two of these acidic residues are directly involved in coordinating a divalent metal ion: The substitution of Cys for Asp allows rescue of some catalytic function, whereas an alanine substitution is no longer subject to iron-induced hydroxyl radical cleavage. Our results support a model in which the RAG1 protein contains the active site of the V(D)J recombinase and are interpreted in light of predictions about the structure of RAG1. FAU - Kim, D R AU - Kim DR AD - Molecular Biology Department, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. FAU - Dai, Y AU - Dai Y FAU - Mundy, C L AU - Mundy CL FAU - Yang, W AU - Yang W FAU - Oettinger, M A AU - Oettinger MA LA - eng GR - GM58026/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 0 (DNA-Binding Proteins) RN - 0 (Homeodomain Proteins) RN - 0 (Nuclear Proteins) RN - 0 (RAG2 protein, human) RN - 0 (Rag2 protein, mouse) RN - 0 (Recombinant Fusion Proteins) RN - 0 (V(D)J recombination activating protein 2) RN - 128559-51-3 (RAG-1 protein) RN - 30KYC7MIAI (Aspartic Acid) RN - 3352-57-6 (Hydroxyl Radical) RN - 42Z2K6ZL8P (Manganese) RN - E1UOL152H7 (Iron) RN - EC 2.7.7.- (DNA Nucleotidyltransferases) RN - EC 2.7.7.- (VDJ Recombinases) SB - IM MH - Amino Acid Sequence MH - Amino Acid Substitution MH - Animals MH - Aspartic Acid/chemistry MH - Binding Sites MH - Catalytic Domain MH - DNA Nucleotidyltransferases/*chemistry/metabolism MH - DNA-Binding Proteins MH - Gene Rearrangement/*physiology MH - HeLa Cells MH - Homeodomain Proteins/*chemistry/genetics/metabolism MH - Humans MH - Hydroxyl Radical MH - Iron/pharmacology MH - Manganese/pharmacology MH - Mice MH - Molecular Sequence Data MH - Mutagenesis, Site-Directed MH - Nuclear Proteins MH - Phenotype MH - Protein Binding MH - Protein Structure, Secondary MH - Protein Structure, Tertiary MH - Recombinant Fusion Proteins/physiology MH - Structure-Activity Relationship MH - VDJ Recombinases PMC - PMC317176 EDAT- 1999/12/22 00:00 MHDA- 1999/12/22 00:01 CRDT- 1999/12/22 00:00 PHST- 1999/12/22 00:00 [pubmed] PHST- 1999/12/22 00:01 [medline] PHST- 1999/12/22 00:00 [entrez] AID - 10.1101/gad.13.23.3070 [doi] PST - ppublish SO - Genes Dev. 1999 Dec 1;13(23):3070-80. doi: 10.1101/gad.13.23.3070.